The Artificial Intelligence in Genomics Market was valued at USD 0.6 Billion in 2023 and is estimated to reach USD 12.48 Billion by 2033, growing at a CAGR of 40.6 % from 2024 to 2033.  

Scope of the market:

A biology field that studies the function, structure, and evolution of genomes which is the set of genetic information present in the DNA of an organism. In recent years artificial intelligence (AI) has made a significant contribution to this market. AI techniques such as machine learning and deep learning are applied to genomic data to make predictions for an individual's health, develop personalized treatments, and identify potential diseases that cause mutation.

The ability to extract valuable data from genomic data has propelled genomic research and has contributed to Artificial Intelligence in Genomics Market. Researchers have made the artificial Intelligence tool to forecast how genome editing repaid choices will be conducted and minimize mistakes in treating genetic illness. This technology accelerates the development of genetic treatment improves accuracy, and facilitates personalized medicines.

Economic Impact of Covid-19:

COVID-19 has positively impacted the growth of Artificial Intelligence in the Genomics Market as it boosted the development of computing solutions that speed up the scale and severity of the pandemic. COVID-19 also gave opportunities for drug discovery, development, and diagnostics which resulted in expansion of the market. AI-driven diagnostics has also emerged as the best solution for faster diagnosis.

However, due to the challenge faced by the healthcare system and economies, quarantine protocols. Closing borders, restricting travel, and fewer social activities hampered the growth of Artificial Intelligence in the Genomics Market.

Key Players:

• Deep Genomics
• Data4cure Inc.
• BenevolentAI Limited
• Congenica Ltd
• Predictive Oncology Inc
• SOPHIA GENETICS SA
• Microsoft Corporation
• NVIDIA Corporation
• Fabric Genomics
• Thermo Fisher Scientific Inc
• Bluebee
• ZS Genetics
• Envisagenics
• Shivom & Bluegnome
• Nebula Genomics
• Others

The above key players in the Artificial Intelligence in Genomics Market can be changed according to the client’s requirements.

Moreover, the key players aim towards expansion, joint ventures, collaboration, mergers, and acquisitions to advance capabilities in the Artificial Intelligence in Genomics Market. In recent years there have been many mergers and acquisitions in private cord blood banks owned by the same parent company with different names.

Recent Developments in Artificial Intelligence in Genomics Market.

In 2023: Genomics AI firm Genomenon acquires Boston Genetics.

The human Genome by combining its AI- enabled genomic platform and expertise with insights from genetics team of Boston. This partnership will enable great support to its clinical diagnostics and pharmaceutical clients making them understand the genomic drivers of genetic disease and oncology. This acquisition adds more than 75 trained genetics scientists, doubling the size.

Artificial Intelligence in Genomics Market: Key Benefits:

1. The report provides information regarding key drivers, restraints, and opportunities with impact analysis.
2. Quantitative and Qualitative analysis of the current market.
3. Estimations for the forecast period 2033.
4. Historical data and forecast data.
5. Recent developments and trends in the market.   
6. Market share of the market players, company profiles, SWOT analysis, and competitive landscape.
7. Covid-19 Impact analysis

Global AI in Genomics Market Segmentation:

By Components:

• Software
• Hardware
• Other

By Technology:

• Machine Learning

1. Deep Learning
2. Unsupervised Learning
3. Supervised Learning
4. Others

• Computer Vision

By Functionality:

• Genome Sequencing
• Gene Editing
• Predictive
• Others

By Application:

• Precision Medicine
• Drug Discovery & Development
• Diagnostics
• Others

By End Use:

• Healthcare Providers
• Research Center
• Pharmaceutical and Biotech Companies
• Others

By Region:

Asia-Pacific

• Japan
• China
• India
• Australia
• New Zealand
• Rest of Asia-Pacific

North America

• US
• Canada
• Mexico

Europe

• Germany
• France
• Italy    
• Spain
• UK
• Rest of Europe

The rest of the World

Each of the market segments has been analyzed in detail for market trends, recent trends and developments, drivers, restraints, opportunities, and competitive analysis.

Research Scope:

Report Scope	Details
Base Year	2023
Historical Years	2019 to 2022
Forecast Years	2024 to 2033
Market Size 2023	USD  0.6 BN
Market Revenue 2033	USD 12.48 BN
Growth Rate 2024- 2033	40.6 %
Report Coverage	Trends, SWOT Analysis, Competitive Landscape, DROs, Revenue Forecast, PEST Analysis.
Segments Covered	Components, Technology, Functionality, Application, End-Use, Region
Companies Mentioned	Deep Genomics, Data4cure Inc, BenevolentAI Limited, Congenica Ltd, Predictive Oncology Inc, SOPHIA GENETICS SA, Microsoft Corporation, NVIDIA Corporation, Fabric Genomics, Thermo Fisher Scientific Inc, Bluebee, ZS Genetics, Envisagenics, Shivom & Bluegnome, Nebula Genomics
Customization	Yes

 

Regional Analysis:

North America holds the largest share of the AI market in genomics. The research funding received by IT companies and biotech from private and government in this region. Increasing adoption of AI in drug development by biotechnology companies and the rise in the healthcare and IT industry driving the growth of the market. Further, the presence of a geriatric population in the US region and the increasing prevalence of chronic disease have increased the demand for AI-based technology in the healthcare industry. The rising demand for faster treatment and demand for innovative drugs is expected to boost the market in the North American region.

Asia Pacific is expected to grow with the highest CAGR of 48.1% during the forecast years. The increasing use of AI in fields such as agriculture, drug discovery, animal research, and diagnostics is driving artificial intelligence in the genomics market in the Asia Pacific region. The rapidly increasing healthcare expenditure, technological advancement, growing focus on medicines, and large population will further drive this market.

Genomics is one of the top domains in Singapore's healthcare systems in 2020 they launched the national precision medicine strategy (NPM) as a part of RIE 2020. This strategy has assisted the growth of the market size of the genomics industry of Asia Pacific. This was valued at 4.45 billion SGD in 2020 and is estimated to reach 7.33 billion SGD by 2025. In this strategy, the third phase involves diffusing precision medicine and its expansion of Singapore’s genetic database which will involve 1 million citizens. This plan will be launched in 2024.

Key questions answered by this report.

1. Top market players contributing to the revenue?
2. Trending strategies by the players?
3. Which region will be the leading one in the forecast period?
4. Factors that drive the Artificial Intelligence in Genomics Market?
5. Which factors will affect the Artificial Intelligence in Genomics Market?
6. How Covid-19 pandemic impacted the growth of the Artificial Intelligence in Genomics Market?
7. Which Segment accounted for the Artificial Intelligence in Genomics Market shares?

 

Frequently Asked Questions (FAQ) :